Alison Yeomans
0000-0001-9125-0379
Publication & Citation Trends
Publications
0 total
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy OA
Cited by 4
Semantic Scholar
B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells OA
Cited by 6
Semantic Scholar
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature OA
Cited by 49
Semantic Scholar
Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells OA
Cited by 27
Semantic Scholar
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination OA
Cited by 15
Semantic Scholar
Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms OA
Cited by 8
Semantic Scholar
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas OA
Cited by 49
Semantic Scholar
Upregulation of epithelial metallothioneins by metal-rich ultrafine particulate matter from an underground railway. OA
Cited by 8
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(11)
Lymphoma Diagnosis and Treatment
(8)
SARS-CoV-2 and COVID-19 Research
(6)
PI3K/AKT/mTOR signaling in cancer
(6)
Cancer-related gene regulation
(5)
Affiliations
Cancer Research UK
Southampton General Hospital
University Hospital Southampton NHS Foundation Trust
Drug Safety Research Unit
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"